MAaGI has been awarded support under the "Science and Technology Innovation Action Plan" Innovation Fund for Technology‑Based Small and Medium‑Sized Enterprises in Shanghai for the year 2024.

2024-12-16

Recently, the Shanghai Science and Technology Commission announced the "List of Approved Projects for the 2024 'Science and Technology Innovation Action Plan' Innovation Fund for Technology‑Based Small and Medium‑Sized Enterprises." The "Multimodal Tumor Ablation Precision Diagnosis and Treatment Software Platform" project, submitted by Shanghai MAaGI Medical Technology Co., Ltd., has been successfully selected.

The "Innovation Fund for Technology‑Based Small and Medium‑Sized Enterprises" is a science and technology innovation funding program organized and implemented by the Shanghai Municipal Science and Technology Commission. It aims to further implement the innovation‑driven development strategy, enhance support for local technology‑based SMEs, and encourage enterprises to carry out technological innovation.

The "Multimodal Tumor Ablation Precision Diagnosis and Treatment Software Platform" developed by MAaGI Medical closely aligns with the clinical needs of multimodal tumor therapy. It integrates multiple core functions including preoperative planning, intraoperative real‑time monitoring, postoperative efficacy evaluation, and image segmentation and registration, providing comprehensive technical support for multimodal tumor treatment. Derived from this platform, the "Medical Image Processing Software" has successfully obtained a Class II Medical Device Registration Certificate (Shanghai Device Registration No. 20242210088), marking an important step forward for M‑Jay Medical in the field of tumor precision diagnosis and treatment. After acquiring medical images, this software enables cross‑modal segmentation, registration, and fusion, integrates multiple medical imaging modalities, comprehensively presents tumor lesions and surrounding tissue information, assists physicians in accurate preoperative planning, precise intraoperative operations, and reliable postoperative evaluation, significantly improving treatment accuracy and safeguarding the patient treatment process.

Following a process of open application submission, review and recommendation by district-level science and technology authorities and the Lingang New Area Administrative Committee, preliminary evaluation, final‑round roadshow presentations, and online public notice, the "Multimodal Tumor Ablation Precision Diagnosis and Treatment Software Platform" project stood out among numerous submissions and has been officially included in the list of projects approved for funding under the Innovation Fund for Technology‑Based Small and Medium‑Sized Enterprises. The project will receive corresponding financial support.

This approval fully reflects the recognition by the competent authorities of the innovation and clinical value of the "Multimodal Tumor Ablation Precision Diagnosis and Treatment Software Platform," and provides strong support for further development and optimization of the software. Encouraged by this achievement, Magic Medical will continue to deepen its commitment to the field of tumor therapy, delivering more precise, durable, and personalized new solutions for patients.

Prev：MAaGI Medical’s “ Multimodal Tumor Thermal Therapy System Approved for Market Launch

Next：Breakthrough in Minimally Invasive Lung Multimodal Tumor Thermal Therapy System Expands Indications to Include Lung Cancer

HOT

: MAaGI Medical R&D Project Selected for Shanghai's 2025 "Science and Technology Innovation Action Plan" Biomedical Innovation Development Program

2025-06-23

: Breakthrough in Minimally Invasive Lung Multimodal Tumor Thermal Therapy System Expands Indications to Include Lung Cancer

2025-04-25

: MAaGI has been awarded support under the "Science and Technology Innovation Action Plan" Innovation Fund for Technology‑Based Small and Medium‑Sized Enterprises in Shanghai for the year 2024.

2024-12-16

: MAaGI Medical’s “ Multimodal Tumor Thermal Therapy System Approved for Market Launch

2023-06-12

: MAaGI Medical Wins “Outstanding Enterprise” Award at the National Biomedical Competition of China Innovation & Entrepreneurship Competition

2022-09-24

MAaGI has been awarded support under the "Science and Technology Innovation Action Plan" Innovation Fund for Technology‑Based Small and Medium‑Sized Enterprises in Shanghai for the year 2024.

MAaGI Medical R&D Project Selected for Shanghai's 2025 "Science and Technology Innovation Action Plan" Biomedical Innovation Development Program

Breakthrough in Minimally Invasive Lung Multimodal Tumor Thermal Therapy System Expands Indications to Include Lung Cancer

MAaGI has been awarded support under the "Science and Technology Innovation Action Plan" Innovation Fund for Technology‑Based Small and Medium‑Sized Enterprises in Shanghai for the year 2024.

MAaGI Medical’s “ Multimodal Tumor Thermal Therapy System Approved for Market Launch

MAaGI Medical Wins “Outstanding Enterprise” Award at the National Biomedical Competition of China Innovation & Entrepreneurship Competition